Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 October 2008

Heart. Published Online First: 8 May 2008. doi:10.1136/hrt.2007.127241
Copyright © 2008 BMJ Publishing Group Ltd & British Cardiovascular Society

Original articles

Homozygous mutation of MYBPC3 associated with severe infantile hypertrophic cardiomyopathy at high frequency amongst the Amish

Kenneth Zahka 1, Kamini Kalidas 2, Michael A Simpson 2, Harold Cross 3, Bradley Keller 4, Csaba Galambos 4, Kay Gurtz 5, Michael A Patton 2 and Andrew H Crosby 2*

1 Rainbow Babies and Children's Hospital, Case Western Reserve University, United States
2 St George's University of London, United Kingdom
3 University of Arizona School of Medicine, United States
4 Children's Hospital of Pittsburgh of UPMC, United States
5 Windows of Hope Genetic Studies, United States

* To whom correspondence should be addressed. E-mail: acrosby{at}sgul.ac.uk.

Accepted 8 April 2008


Abstract

Background Familial hypertrophic cardiomyopathy (HCM) is a leading cause of sudden cardiac death amongst young and apparently healthy individuals. Mutations within genes encoding sarcomeric proteins have so far been defined and act in an autosomal dominant fashion. We have identified an autosomal recessive form of HCM within a group of Amish children that is associated with very poor prognosis and death within the 1st year of life. Affected patients experienced progressive cardiac failure despite maximal medical therapy. Post-mortem histology revealed myofiber disarray and myocyte loss consistent with refractory clinical deterioration in affected infants.

Methods and results Assuming that a founder mutation was responsible we conducted a genome-wide screen for linkage and identified an autozygous region of chromosome 11 which cosegregates with the infant cardiac phenotype. This region contained the MYBPC3 gene, which has previously been associated with autosomal dominant adult onset HCM. Sequence analysis of the MYBPC3 gene identified a splice site mutation in intron 30 which was homozygous in all affected infants. All surviving patients with the homozygous MYBPC3 gene mutations (3330+2T>G) have been treated by orthotopic heart transplantation.

Conclusions We define homozygous mutations in the MYBPC3 gene as the cause of severe infantile hypertophic cardiomyopathy amongst the Amish.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.